Patient info

Normicron 200 mg film-coated tablets – patient leaflet, side effects, dosage

Medicine strength:
200 mg
Contains active substance:
ATC code:

Patient leaflet - Normicron 200 mg film-coated tablets

1. WHAT NORMICRON 200 MG FILM-COATED TABLETS ARE AND WHAT IT IS USED FOR

Normicron 200 mg film-coated tablets contain the active substance Rifaximin, an intestinal antibiotic used to treat:

  • traveller´s diarrhoea in adults when the diarrhoea is not accompanied by fever or blood in the stools, or 8 or more unformed (soft or liquid) stools in the last 24 hours.

Normicron 200 mg film-coated tablets are not recommended for use in children (aged less than 18 years).

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NORMICRON 200 MG FILM-COATED TABLETS

Do not take Normicron 200 mg film-coated tablets

  • if you are allergic (hypersensitive) to rifaximin, to similar types of antibiotics (such as rifampicin or rifabutin) or to any of the other ingredients of this medicine (listed in section 6);
  • if you have a fever;
  • if you have blood in your stools;
  • if you passed 8 or more unformed stools in the last 24 hours;
  • if you have constipation, abdominal pain and vomiting caused by blockage of the bowel.

Warning and Precautions

Talk to your doctor or pharmacist before taking Normicron 200 mg film-coated tablets.

Take special care:

  • if you have ever developed a severe skin rash or skin peeling, blistering and/or mouth sores after taking rifaximin. Serious skin reactions, including Stevens-Johnson syndrome and toxic

    • epidermal necrolysis, have been reported in association with rifaximin treatment. Most of the cases were reported in patients with liver disease (such as cirrhosis or hepatitis). Stop using Normicron 200 mg film-coated tablets and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4;
  • if, after 3 days of treatment, your symptoms continue or re-appear shortly afterwards do not take a second course of Normicron 200 mg film-coated tablets, see a doctor;
  • if your symptoms get worse during treatment stop taking Normicron 200 mg film-coated tablets and consult a doctor.

Normicron contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

Other medicines and Normicron 200mg film-coated tablets

Please tell your doctor or pharmacist if you are taking, have recently taken any other medicines, including medicines obtained without a prescription.

Please tell your doctor if you are taking ciclosporin (a medicine to suppress the body’s immune system), warfarin (medicine to prevent blood clotting) or oral contraceptives (medicine to prevent pregnancy).

If you are using activated charcoal (for example to treat wind or diarrhoea) please take Normicron 200 mg film-coated tablets at least 2 hours after taking charcoal.

Normicron 200 mg film-coated tablets with food and drink

These tablets should be swallowed whole with a drink of water. They may be taken with or without food.

Taking this medicine may cause a reddish discolouration of your urine.

Pregnancy, breast-feeding and fertility

Normicron 200 mg film-coated tablets are not recommended during pregnancy or in women of childbearing potential not using contraception.

Inform your doctor

  • if you are pregnant, think you may be pregnant or are thinking of becoming pregnant;
  • if you are breast-feeding or planning to start breast-feeding.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Normicron 200 mg film-coated tablets are unlikely to affect your reactions when driving or using machines.

If you feel dizzy or drowsy you should not drive or operate machinery.

3. HOW TO TAKE NORMICRON 200 MG FILM-COATED TABLETS

Always take Normicron 200 mg film-coated tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

  • Unless otherwise prescribed by the doctor, the usual dose is 1 tablet every 8 hours (600 mg/day). You should continue taking Normicron 200 mg film-coated tablets for three days even if your symptoms have improved.
  • Unless otherwise prescribed, the duration of the treatment should not exceed three days. If your symptoms persist for more than three days please see a doctor.

Do not break or crush the tablets.

If you take more Normicron 200 mg film-coated tablets than you should

If you take more than the recommended number of tablets, please contact a doctor.

If you forget to take Normicron 200 mg film-coated tablets

  • take the missed dose as soon as you remember and take the next scheduled dose at its regular time.

If you stop taking Normicron 200 mg film-coated tablets

If you do not complete the three days of treatment recommended, your symptoms may worsen.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Normicron 200 mg film-coated tablets can cause side effects, although not everybody gets them.

If you have any of the following side effects stop taking Normicron 200 mg film-coated tablets and seek urgent medical advice.

Not known (frequency cannot be estimated from the available data)

  • Reddish non-elevated, target-like or circular patches on the trunk, often with central blisters, skin peeling, ulcers of mouth, throat, nose, genitals and eyes. These serious skin rashes can be preceded by fever and flu-like symptoms
  • Allergic reactions, symptoms may include:

    • rash, hives or itchy skin
    • shortness of breath, wheezing
    • heart racing
    • swelling of the mouth, face, ankles or any other part of the body
    • extreme tiredness, dizziness or feeling faint

Common (may affect up to 1 in 10 people):

  • Headache
  • wind, abdominal bloating, abdominal pain, constipation, diarrhoea, urgency to empty your bowels, nausea, involuntary and painful or ineffective straining, vomiting
  • fever

Uncommon (may affect up to 1 in 100 people):

  • Thrush, cold sore, inflammation or infection of the nose and throat
  • abnormal test results in white blood cells
  • loss of appetite, loss of body fluid (dehydration)
  • abnormal dreams, depressed mood, sleeplessness, nervousness
  • numbness, migraine, pins and needles, sinus headache, drowsiness
  • double vision
  • earache, sensation of the room going round (vertigo)
  • increased blood pressure, hot flushes
  • cough, dry throat, blocked nose, sore throat, runny nose
  • upper abdominal pain, indigestion, intestinal movement disorder, dry lips, hard stools, blood in the stools, mucus in stools, taste disorders
  • blood test results: increased liver enzyme values
  • sunburn
  • back pain, muscle cramps, muscle weakness, muscle pain, neck pain
  • abnormal urine test results: blood in urine, protein in urine, sugar in urine
  • frequent urination, excessive urination
  • frequent periods
  • chills, cold sweat, increased sweating, flu-like illness, pain

The following side effects have been reported, however their frequency cannot be estimated from the available data:

  • Bacterial infections
  • abnormal blood tests results (blood not clotting normally and abnormal liver tests)
  • allergic reactions to the drug
  • skin roughness, skin redness, skin with little purple-coloured spots

Treatment with any antibiotic may cause Clostridioides difficile associated diarrhoea (CDAD).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE NORMICRON 200 MG FILM-COATED TABLETS

Keep out of the sight and reach of children.

Normicron 200 mg film-coated tablets do not require any special storage conditions.

Do not use Normicron 200 mg film-coated tablets after the expiry date which is stated on the carton and the blister. The expiry date refers to the last day of that month.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Normicron 200 mg film-coated tablets contain

  • The active substance is: Rifaximin. Each film-coated tablet contains: 200 mg of Rifaximin. The other ingredients are:

    Tablet core: sodium starch glycolate Type A, glycerol distearate (Type I), colloidal anhydrous silica, talc, microcrystalline cellulose.

    Tablet coat (Opadry II 85F94190 Pink): poly(vinyl alcohol), titanium dioxide (E171), talc, macrogol 4000 (polyethylene glycol), red iron oxide (E172).

What Normicron 200 mg film-coated tablets look like and contents of the pack

  • Normicron 200 mg film-coated tablets are pink circular biconvex coated tablets, with “AW” embossed on one side.
  • They are provided in blister pack containing 9 tablets.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Alfasigma S.p.A.

Via Ragazzi del ’99, n.5 – 40133 Bologna (BO), ITALY

Manufacturer

Alfasigma S.p.A.

Via E. Fermi, 1 – 65020 Alanno (PE), ITALY

This leaflet was last revised in

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 48053/0006

MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Normicron 200 mg film-coated tablets

Active substance Rifaximin
Strength 200 mg
Drug group (ATC)
  1. A Alimentary tract and metabolism drugs
    1. A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents
      1. A07A Intestinal antiinfectives
        1. A07AA Antibiotics, intestinal
          1. A07AA11 rifaximin
Marketing authorisation PL 48053/0006

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.